(Q74637041)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190145%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

editorial

0 references

title

Crohn's disease, TNF-alpha, and the leaky gut. The chicken or the egg? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190145%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

Daniel Hollander

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190145%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190145%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190145%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190145%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190145%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

1867-1868

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190145%20AND%20SRC:MED&resulttype=core&format=json

Changes in the incidence of inflammatory bowel disease: what does it mean?

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05895.X

Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05895.X

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05895.X

Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05895.X

Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05895.X

Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05895.X

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05895.X

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05895.X

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05895.X

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05895.X

10.1111/J.1572-0241.2002.05895.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190145%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference